USE OF ATTENUATED STRAINS OF TOXOPLASMA FOR THE PREVENTION OR TREATMENT OF CRYPTOSPORIDIOSIS
The present invention concerns strains of Sarcocystidae chosen from Toxoplasma spp or Neospora spp isolated from the natural environment of same and having an immunostimulating effect for the use of same in the prevention or treatment, in a mammal, of a pathology associated with an apicomplexan of the Cryptosporidium family.